Inhalation of airborne fine particulate matter (PM
2.5
), dust ingestion, and dermal contact with dust are important
pathways
for human exposure to different contaminants, such as organophosphate
esters (OPE), compounds that are widely used as flame retardants and
plasticizers. There are limited studies assessing the extent of the
contamination of OPE in indoor airborne PM
2.5
. This study
offers a novel approach by examining various indoor environments,
such as homes, workplaces, and means of transport, where people typically
spend their daily lives. The goal is to provide a comprehensive assessment
of daily exposure to these pollutants. Both PM
2.5
and dust
samples were collected in order to determine the concentration levels
of 17 different OPEs. Fifteen OPEs in PM
2.5
and 16 in dust
samples were detected. Concentration levels in indoor air ranged from
4.37 to 185 ng/m
3
(median 24.4 ng/m
3
) and from
3.02 to 36.9 μg/g for the dust samples (median 10.2 μg/g).
Estimated daily intakes (EDIs) of OPEs were calculated for adults,
yielding median values of 3.97 ng/(kg bw × day) for EDI
Inhalation
, 5.89 ng/(kg bw × day) for EDI
Dermal
, and 1.75 ng/(kg
bw × day) for EDI
Ingestion
. Such levels lie below
human health threshold risk limits, although in some cases they could
be only 2 times below the threshold for carcinogenic risk, with a
main contribution from tris(2-chloroethyl) phosphate (TCEP). Given
this threshold proximity, additional exposure to these chemicals from
other pathways, such as food ingestion, gas phase exposure, and/or
inhalation of coarser particles (PM
10–2.5
), could
therefore lead to health limit exceedances.